OxyContin is a prescription opioid developed by Purdue Pharma. It has faced lawsuits over addiction and misuse; Purdue reorganized under a new entity to address opioid crisis after settlements. Walmart settlement adds to broader industry-wide settlements.
The U.S. Department of Justice and Walmart have reached a settlement over claims that Walmart pharmacies violated the Controlled Substances Act by failing to report red flags tied to opioid prescriptions. Walmart has not admitted liability. The settlement resolves claims from 2013 onward, with earlier related actions already settled in 2022. Walmart shares edged higher after the announcement.